Outcomes of Atherectomy and Balloon Angioplasty Compared to Conventional Angioplasty in Infra-popliteal Chronic Limb-Threatening Ischemia
NCT ID: NCT07120555
Last Updated: 2025-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-09-30
2027-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Conventional balloon angioplasty remains a first-line endovascular treatment but is limited by high restenosis and vessel recoil rates. Atherectomy, a plaque debulking technique, aims to improve luminal gain and vessel compliance prior to angioplasty, potentially enhancing outcomes in heavily calcified lesions. The combination of atherectomy and balloon angioplasty has shown promise in reducing dissection rates and improving technical success, yet its superiority over conventional angioplasty alone remains controversial.
Given the growing use of endovascular therapies, a comparative analysis of outcomes between combined atherectomy-balloon angioplasty and conventional angioplasty in infra-popliteal interventions is essential to guide evidence-based management in CLTI patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pedal Arch Revascularization in Patients With Chronic Limb Threatening Ischemia
NCT05098548
Endovascular Treatment of Popliteal Artery - Balloon Angioplasty Versus Primary Stenting
NCT00712309
Outcomes of Straight-line Flow Versus Angiosome-targeted Angioplasty in Treatment of Critical Lower Limb Ischemia
NCT06127134
Oucomes of Endovascular Atherectomy in Femoropopliteal Arterial Disease
NCT07239089
PTA vs. CB-PTA for Treatment of Femoropopliteal Artery In-Stent Restenosis
NCT00481780
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
atherectomy + balloon angioplasty
atherectomy
Conventional balloon angioplasty remains a first-line endovascular treatment but is limited by high restenosis and vessel recoil rates. Atherectomy, a plaque debulking technique, aims to improve luminal gain and vessel compliance prior to angioplasty, potentially enhancing outcomes in heavily calcified lesions. The combination of atherectomy and balloon angioplasty has shown promise in reducing dissection rates and improving technical success, yet its superiority over conventional angioplasty alone remains controversial.
conventional balloon angioplasty
Percutaneous transluminal angioplasty of infra-popliteal arteries lesions with primary long
Percutaneous transluminal angioplasty of infra-popliteal arteries lesions with primary long
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
atherectomy
Conventional balloon angioplasty remains a first-line endovascular treatment but is limited by high restenosis and vessel recoil rates. Atherectomy, a plaque debulking technique, aims to improve luminal gain and vessel compliance prior to angioplasty, potentially enhancing outcomes in heavily calcified lesions. The combination of atherectomy and balloon angioplasty has shown promise in reducing dissection rates and improving technical success, yet its superiority over conventional angioplasty alone remains controversial.
Percutaneous transluminal angioplasty of infra-popliteal arteries lesions with primary long
Percutaneous transluminal angioplasty of infra-popliteal arteries lesions with primary long
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Denovo or Recoil
* Reference tibial vessel diameter at least (2mm)
* The diseased tibial artery has a patent distal segment supplying the foot
Exclusion Criteria
* Previous ipsilateral infrapopliteal bypass surgery
* Concomitant iliac or femoral artery lesion
* Isolated pedal arch disease
* previous atherectomy
* Faliure to cross the lesion
* Known hypercoagulable disorder or non-atherosclerotic vasculopathy
* Severe renal insufficiency (eGFR \<30) not on dialysis
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Moustafa Farouk
assistant lecturer
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DFGCUOHBTR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.